- Report
- April 2024
- 80 Pages
Japan
From €1434EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
Poland
From €1434EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
Russia
From €1434EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
Saudi Arabia
From €1434EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
South Korea
From €1434EUR$1,500USD£1,200GBP
From €1434EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €1434EUR$1,500USD£1,200GBP
- Report
- April 2024
- 80 Pages
Vietnam
From €1434EUR$1,500USD£1,200GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €478EUR$500USD£400GBP
- Report
- March 2025
- 81 Pages
Global
From €3500EUR$3,921USD£3,032GBP
- Report
- August 2024
- 90 Pages
Global
From €3500EUR$3,921USD£3,032GBP
Cialis is a drug used to treat erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). It belongs to a class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors, which work by increasing blood flow to the penis. Cialis is one of the most popular drugs in the Sexual and Reproductive Health Drugs market. It is used to treat ED and BPH, as well as other conditions such as pulmonary arterial hypertension. Cialis is available in both brand and generic forms, and is taken orally.
Cialis is a widely used drug in the Sexual and Reproductive Health Drugs market. It is used to treat ED and BPH, as well as other conditions. It is available in both brand and generic forms, and is taken orally. Cialis is a safe and effective treatment for ED and BPH, and is well tolerated by most patients.
Some companies in the Cialis market include Eli Lilly, Pfizer, Bayer, and GlaxoSmithKline. Show Less Read more